Synchron
AI | HealthTech

Improving Lives via the Brain-Computer Interface

overview

Brain Computer Interface for Paralyzed Patients

Synchron is pioneering the field of brain-computer interfaces (BCI) with its innovative, minimally-invasive technology. Their flagship product, the Synchron BCI, is designed to be implanted via endovascular procedures, similar to stent placement, avoiding the need for open brain surgery. This approach allows for safer and more accessible treatment options for patients with severe paralysis. By leveraging real-time AI computing from NVIDIA and integration with devices like Apple Vision Pro, Synchron's BCI enables patients to control digital devices and communicate using their thoughts. The company's mission is to empower individuals with disabilities to regain autonomy and social connection, transforming lives through cutting-edge neurotechnology.

No items found.
Results

A Bet on the Operating System of the Brain

We invested recognizing Synchron's structural advantages in both regulatory timeline and market access. The company raised a $200M Series D in late 2025, backed by Double Point Ventures, ARCH Venture Partners, Khosla Ventures, Bezos Expeditions, and more. As the company enters pivotal trials in 2026, Synchron stands as the primary gateway to "digital agency" for millions of people worldwide living with upper-limb impairment and paralysis.